Hiroyuki Morimoto Selected Research

calyculin A

8/2007	Calyculin A induces apoptosis and stimulates phosphorylation of p65NF-kappaB in human osteoblastic osteosarcoma MG63 cells.
1/2005	PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Morimoto Research Topics

Disease

6	Neoplasms (Cancer) 11/2019 - 05/2003
6	Osteosarcoma (Osteogenic Sarcoma) 10/2016 - 10/2004
2	Pathologic Constriction (Stenosis) 09/2017 - 12/2016
2	Esophageal Neoplasms (Esophageal Cancer) 09/2017 - 03/2014
2	Inflammation (Inflammations) 11/2016 - 12/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2005 - 10/2004
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 06/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020
1	Body Weight (Weight, Body) 11/2019
1	Stomach Neoplasms (Stomach Cancer) 05/2018
1	Deglutition Disorders (Dysphagia) 09/2017
1	Fistula 09/2017
1	Esophageal Stenosis (Esophageal Stricture) 09/2017
1	Pleural Effusion (Pleural Effusions) 01/2017
1	Ulcer 12/2016
1	Esophageal Squamous Cell Carcinoma 12/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Cholesteatoma 01/2014
1	Fibrosis (Cirrhosis) 09/2013
1	Peritoneal Fibrosis 09/2013
1	Starvation 12/2012
1	Virus Diseases (Viral Diseases) 12/2012
1	Ischemia 12/2012

Drug/Important Bio-Agent (IBA)

4	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 06/2013 - 10/2004
4	Okadaic AcidIBA 06/2013 - 10/2004
2	Pharmaceutical PreparationsIBA 03/2014 - 10/2004
2	calyculin AIBA 08/2007 - 01/2005
2	Transcription Factors (Transcription Factor)IBA 12/2006 - 10/2004
2	Threonine (L-Threonine)FDA Link 12/2006 - 10/2004
2	Serine (L-Serine)FDA Link 12/2006 - 10/2004
1	TriterpenesIBA 06/2022
1	CaspasesIBA 06/2022
1	Oleanolic AcidIBA 06/2022
1	Ursolic AcidIBA 06/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	SandIBA 10/2020
1	Particulate MatterIBA 10/2020
1	polyoxyethylene(10)nonylphenyl ether (NP 10)IBA 11/2019
1	Antimitotic AgentsIBA 11/2019
1	SteroidsIBA 12/2016
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 12/2016
1	Pattern Recognition ReceptorsIBA 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2016
1	TubulinIBA 09/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2015
1	carbazoleIBA 09/2015
1	taxaneIBA 09/2015
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2014
1	Photosensitizing Agents (Photosensitizers)IBA 03/2014
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 03/2014
1	LanthanumIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	AcidsIBA 01/2014
1	Keratins (Keratin)IBA 01/2014
1	Filaggrin ProteinsIBA 01/2014
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 12/2012
1	von Willebrand FactorIBA 11/2009
1	NF-kappa B (NF-kB)IBA 12/2006
1	NF-KappaB Inhibitor alphaIBA 08/2005

Therapy/Procedure

2	Chemoradiotherapy 09/2017 - 03/2014
2	Peritoneal Dialysis 11/2016 - 09/2013
2	Lasers (Laser) 03/2014 - 01/2014
1	Traction 05/2018
1	Endoscopes 09/2017
1	Stents 09/2017
1	Aftercare (After-Treatment) 09/2017
1	Conservative Treatment 01/2017
1	Injections 12/2016
1	Drug Therapy (Chemotherapy) 09/2015
1	Photochemotherapy (Photodynamic Therapy) 03/2014
1	Salvage Therapy 03/2014
1	Dye Lasers 03/2014
1	Therapeutics 09/2013
1	Nephrectomy 05/2003